Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Radiation Oncology
•
Genitourinary Cancers
For patients undergoing bladder preservation therapy with TMT, how do you manage the urinary urgency and frequency during and after treatment?
Related Questions
How do you assess treatment response after prostate XRT in the setting of low volume metastatic disease?
Do you advise Kegels/pelvic floor physical therapy to minimize urinary incontinence when irradiating the prostatic fossa?
Would you use neoadjuvant immunotherapy to spare renal cortex prior to SBRT?
Would you irradiate the elective pelvis of a patient with high risk prostate cancer in the setting of osteoporosis and sacral insufficiency fractures?
Would you offer prostate SBRT to a patient on a TKI?
Given results of BCON trial, do you add carbogen and nicotinamide for patients receiving definitive radiotherapy for bladder cancer, particularly for non-cisplatin eligible candidates?
Would you offer adjuvant XRT to the prostate fossa in a patient with Lynch Syndrome?
Do you include the prostate when treating bladder cancer?
Would you recommend radiation to the prostate after prior transurethral ultrasound ablation (TULSA PRO)?
What are your top takeaways from ASCO GU 2024?